Summary & Overview
CPT 15788: Chemical Peel (Chemexfoliation) for Skin Resurfacing
CPT code 15788 represents a chemical peel (chemexfoliation), a dermatologic procedure using controlled chemical agents to remove superficial scars, sun damage, or acne by affecting the epidermis and potentially the dermis. This code captures a common cosmetic and therapeutic skin-resurfacing service performed in outpatient dermatology and plastic surgery settings and matters nationally because of its frequency in ambulatory care and its intersections with cosmetic versus medically necessary coverage policies.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context, typical sites of service, and payer coverage considerations relevant to these major national payers. The publication summarizes common billing and coding issues, benchmarks where available, and policy considerations that influence coverage determinations and documentation expectations.
The report provides practical reference material: an explanation of the service coded by 15788, typical clinical indications and procedural settings, and an outline of the payer landscape and what clinicians and billing staff should expect when submitting claims. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 15788 describes a chemical peel (chemexfoliation): the controlled application of chemical agents (for example, alpha–hydroxy acid, retinoic acid, or phenol) to remove superficial scarring, sun damage, or acne. The procedure involves the epidermis partially or completely and may involve the dermis depending on treatment depth and duration.
Service type: Procedural dermatologic cosmetic/excisional skin resurfacing
Typical site of service: Outpatient dermatology or plastic surgery clinic, ambulatory surgical center, or office-based procedure room
Clinical & Coding Specifications
Clinical Context
A 35-year-old female presents to a dermatology clinic for evaluation of facial photodamage and superficial acne scarring. She has medical history notable only for controlled seasonal allergies and desires improvement in skin texture and pigmentation. After a focused skin examination and discussion of options, the dermatologist recommends a superficial to medium-depth chemical peel using alpha-hydroxy acid to remove epidermal damaged layers and stimulate re-epithelialization. The patient is consented for the procedure, topical anesthetic is applied if needed, and the chemical agent is applied in a controlled manner to the target areas. Post-application neutralization and cooling are performed as indicated, and written postoperative care instructions are provided. The clinical workflow includes pre-procedure assessment and informed consent, the procedure in an outpatient clinic or ambulatory surgical center, immediate post-procedure assessment for complications (excessive erythema, blistering), and scheduled follow-up for healing and outcome assessment.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Normal service | Use when the procedure is performed under routine circumstances without unusual effort or circumstances |
22 | Increased procedural services | Use when time, technical difficulty, or increased intensity substantially exceeds the usual service |
23 | Unusual anesthesia | Use when general anesthesia is required for reasons unrelated to the procedure itself |
52 | Reduced services | Use when the procedure is partially reduced or not completed at the physician's discretion |
53 | Discontinued procedure | Use when the procedure is started but terminated due to extenuating circumstances or patient request |
59 | Distinct procedural service | Use when another service is separate and distinct from the chemical peel on the same date |
62 | Two surgeons | Use when two surgeons work together as primary surgeons on the procedure |
78 | Return to OR for related procedure during postoperative period | Use if patient requires return to the operating room for a complication related to the initial procedure |
80 | Assistant surgeon | Use when an assistant surgeon is required for the procedure |
99 | Not listed in input; excluded | Data not available in the input |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
207RP0000X | Dermatology | Dermatologists most commonly perform chemical peels for cosmetic and therapeutic indications |
207RN0401X | Cosmetic Dermatology | Subspecialists focusing on aesthetic procedures who commonly perform chemical peels |
208000000X | General Practice/Family Medicine | Family physicians may perform superficial peels in outpatient office settings |
363L00000X | Plastic Surgery | Plastic surgeons perform peels as part of aesthetic skin resurfacing procedures |
101YP1600X | Internal Medicine (Dermatologic procedures) | Some internists with procedural training perform superficial peels |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
15788 | Chemical peel (chemexfoliation), application of chemical agents to remove superficial scar, sun damage, or acne | Primary code describing the chemical peel procedure itself |
99213 | Office or other outpatient visit, established patient, low to moderate complexity | Pre-procedure evaluation and routine follow-up visits commonly billed before/after the peel |
11900 | Insertion, temporary subcutaneous implant for local drug delivery (not typically used) | Data not available in the input. |
97110 | Therapeutic exercises (example of adjunctive skin therapy) | Occasionally used in multidisciplinary care pathways but not specific to peel procedures |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
L57.0 | Actinic keratosis | Common indication for superficial chemical exfoliation to treat precancerous sun damage |
L91.5 | Scar conditions and fibrosis of skin | Chemical peels can improve superficial scar texture and pigmentation |
L70.0 | Acne vulgaris | Superficial peels are used to treat acne and post-inflammatory hyperpigmentation |
L98.9 | Disorder of skin and subcutaneous tissue, unspecified | Used when specific diagnosis is not otherwise classified but peel is indicated |
F43.21 | Body dysmorphic disorder | Relevant as a screening diagnosis to assess psychological suitability for cosmetic procedures |